Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Impact of Bendamustine Pretreatment on Stem Cell Mobilization and Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Wolfram Pönisch, Julia Wiesler, Ina Wagner, Sabine Leiblein, Elvira Edel, Haifa K. Al-Ali, MD, Vladan Vucinic, Ute Hegenbart, MD, Christiane Heiß, Dietger Niederwieser, MD, Hartmut Goldschmidt, MD

Blood (2011) 118 (21): 1933.

https://doi.org/10.1182/blood.V118.21.1933.1933

Published: 2011

Journal Articles

Successful Mobilization of Peripheral Blood Stem Cells After Intensive Bendamustine Pre-Treatment In Patients with Multiple Myeloma

Wolfram Pönisch, Julia Wiesler, Sabine Leiblein, Elvira Edel, Haifa K. Al-Ali, Nadezda Basara, MD, Ute Hegenbart, Christiane Heiß, Dietger W Niederwieser, MD, Hartmut Goldschmidt

Blood (2010) 116 (21): 4439.

https://doi.org/10.1182/blood.V116.21.4439.4439

Published: 2010

Journal Articles

The Ratio of Pre-Transplant Serum Ferritin to the Units of Blood Transfused and Not Serum Hepcidin Strongly Correlates with Outcome After Allogeneic Hematopoietic Cell Transplantation In Patients with AML and MDS.

Haifa Kathrin Al-Ali, MD, Nadja Jaekel, MD, Rainer Krahl, MD, Elvira Edel, Claudia Wickenhauser, Mark Westerman, Sabine Leiblein, Uwe Gerd Liebert, Marianne Hehme, Dietger W Niederwieser, MD

Blood (2010) 116 (21): 1307.

https://doi.org/10.1182/blood.V116.21.1307.1307

Published: 2010

Journal Articles

Phlebotomy as an Effective Treatment for Iron Overload after Allogeneic Hematopoietic Cell Transplantation: Iron Depletion Kinetics Are Influenced by the Donor Hemochromatosis (HFE) Genotype.

Ann-Kathrin Eisfeld, Medical Student, Ralph Burkhardt, MD, Sabine Schroeder, MD, Rainer Krahl, PhD, Elvira Edel, MD, Christa Doering, Dietger Niederwieser, MD, Haifa K. Al-Ali, MD

Blood (2005) 106 (11): 3717.

https://doi.org/10.1182/blood.V106.11.3717.3717

Published: 2005

Journal Articles

Iron Overload Strongly Correlates with Acute Graft-Versus-Host-Disease of the Liver and Treatment Related Mortality after Allogeneic Hematopoetic Cell Transplantation (HCT).

Ann-Kathrin Eisfeld, Ralph Burkhardt, MD, Daniel Teupser, MD, Sabine Schroeder, MD, Rainer Krahl, PhD, Andrea Junghans, Elvira Edel, MD, Christa Doehring, Uwe G. Liebert, MD, Dietger W. Niederwieser, MD, Haifa K. Al-Ali, MD

Blood (2005) 106 (11): 1812.

https://doi.org/10.1182/blood.V106.11.1812.1812

Published: 2005

Journal Articles

HFE Genotype Is of Donor Origin and Does Not Correlate with Iron Overload Present in Patients after Allogeneic Stem Cell Transplantation.

Ann-Kathrin Eisfeld, Ralph Burkhardt, MD, Daniel Teupser, MD, Sabine Schroeder, MD, Rainer Krahl, PhD, Andrea Junghans, Elvira Edel, MD, Christa Doehring, Joachim Thiery, MD, Dietger W. Niederwieser, MD, Haifa K. Al-Ali

Blood (2004) 104 (11): 3684.

https://doi.org/10.1182/blood.V104.11.3684.3684

Published: 2004

NARROW

Impact of Bendamustine Pretreatment on Stem Cell Mobilization and Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Successful Mobilization of Peripheral Blood Stem Cells After Intensive Bendamustine Pre-Treatment In Patients with Multiple Myeloma

The Ratio of Pre-Transplant Serum Ferritin to the Units of Blood Transfused and Not Serum Hepcidin Strongly Correlates with Outcome After Allogeneic Hematopoietic Cell Transplantation In Patients with AML and MDS.

Phlebotomy as an Effective Treatment for Iron Overload after Allogeneic Hematopoietic Cell Transplantation: Iron Depletion Kinetics Are Influenced by the Donor Hemochromatosis (HFE) Genotype.

Iron Overload Strongly Correlates with Acute Graft-Versus-Host-Disease of the Liver and Treatment Related Mortality after Allogeneic Hematopoetic Cell Transplantation (HCT).

HFE Genotype Is of Donor Origin and Does Not Correlate with Iron Overload Present in Patients after Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Impact of Bendamustine Pretreatment on Stem Cell Mobilization and Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Successful Mobilization of Peripheral Blood Stem Cells After Intensive Bendamustine Pre-Treatment In Patients with Multiple Myeloma

The Ratio of Pre-Transplant Serum Ferritin to the Units of Blood Transfused and Not Serum Hepcidin Strongly Correlates with Outcome After Allogeneic Hematopoietic Cell Transplantation In Patients with AML and MDS.

Phlebotomy as an Effective Treatment for Iron Overload after Allogeneic Hematopoietic Cell Transplantation: Iron Depletion Kinetics Are Influenced by the Donor Hemochromatosis (HFE) Genotype.

Iron Overload Strongly Correlates with Acute Graft-Versus-Host-Disease of the Liver and Treatment Related Mortality after Allogeneic Hematopoetic Cell Transplantation (HCT).

HFE Genotype Is of Donor Origin and Does Not Correlate with Iron Overload Present in Patients after Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only